c-Myc regulates mammalian body size by controlling cell number but not cell size
- PMID: 11742404
- DOI: 10.1038/414768a
c-Myc regulates mammalian body size by controlling cell number but not cell size
Abstract
Overexpression of the proto-oncogene c-myc has been implicated in the genesis of diverse human tumours. c-Myc seems to regulate diverse biological processes, but its role in tumorigenesis and normal physiology remains enigmatic. Here we report the generation of an allelic series of mice in which c-myc expression is incrementally reduced to zero. Fibroblasts from these mice show reduced proliferation and after complete loss of c-Myc function they exit the cell cycle. We show that Myc activity is not needed for cellular growth but does determine the percentage of activated T cells that re-enter the cell cycle. In vivo, reduction of c-Myc levels results in reduced body mass owing to multiorgan hypoplasia, in contrast to Drosophila c-myc mutants, which are smaller as a result of hypotrophy. We find that c-myc substitutes for c-myc in fibroblasts, indicating they have similar biological activities. This suggests there may be fundamental differences in the mechanisms by which mammals and insects control body size. We propose that in mammals c-Myc controls the decision to divide or not to divide and thereby functions as a crucial mediator of signals that determine organ and body size.
Similar articles
-
E2F activity is essential for survival of Myc-overexpressing human cancer cells.Oncogene. 2002 Sep 19;21(42):6498-509. doi: 10.1038/sj.onc.1205828. Oncogene. 2002. PMID: 12226753
-
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.Cancer Cell. 2005 May;7(5):433-44. doi: 10.1016/j.ccr.2005.03.036. Cancer Cell. 2005. PMID: 15894264
-
Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification.J Cell Sci. 2005 Apr 15;118(Pt 8):1693-704. doi: 10.1242/jcs.02298. Epub 2005 Mar 29. J Cell Sci. 2005. PMID: 15797928
-
Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer.Semin Cancer Biol. 1994 Feb;5(1):21-36. Semin Cancer Biol. 1994. PMID: 8186385 Review.
-
The regulation of cell growth and proliferation during organogenesis.In Vivo. 2000 Jan-Feb;14(1):141-8. In Vivo. 2000. PMID: 10757071 Review.
Cited by
-
Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.Int J Mol Sci. 2024 Jan 19;25(2):1265. doi: 10.3390/ijms25021265. Int J Mol Sci. 2024. PMID: 38279262 Free PMC article.
-
Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN.Front Cell Dev Biol. 2022 Sep 16;10:1021820. doi: 10.3389/fcell.2022.1021820. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36187481 Free PMC article. Review.
-
Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.EMBO J. 2002 Sep 16;21(18):4820-30. doi: 10.1093/emboj/cdf492. EMBO J. 2002. PMID: 12234922 Free PMC article.
-
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression.Genes Dev. 2002 Oct 1;16(19):2530-43. doi: 10.1101/gad.1024602. Genes Dev. 2002. PMID: 12368264 Free PMC article.
-
MYC as a regulator of ribosome biogenesis and protein synthesis.Nat Rev Cancer. 2010 Apr;10(4):301-9. doi: 10.1038/nrc2819. Nat Rev Cancer. 2010. PMID: 20332779 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
